AbbVie
ABBVSend this update
AbbVie layoffs: 138 workers · WARN in CA · Dec 16, 2024
Latest WARN names 138 workers in CA.
People who work here
Verify a work email, then post with no name. A poll you start shows in the thread list. It stays open for 3 days unless you pick 1 or 7, and you can close it sooner. A private reply goes to Messages.
Loading…
People in this kind of work also look at
Ask someone who worked here
Ask for a reference, or what the job is really like. The reply goes to a private inbox. Your name stays off this page.
Loading…
Email me about AbbVie
Sign up first. We email the address on that account when a new WARN filing or layoff report is linked to AbbVie.
Checking account…Mail about more than this one employer is Premium: saved WARN searches and a weekly digest. Turn off or switch the employer email from your account.
Where to file if this is your employer
Latest WARN notice: California, 138 workers, notice Oct 23, 2024, layoff date Dec 16, 2024.
California unemployment is listed at up to $450 a week for 26 weeks. A waiting week applies.
File in CaliforniaBenefit amounts are published estimates. Confirm the current rule with the state.
50.0K
$291.42
▲ 1.1%
None(0.3%)
announced Oct 23, 2024
11
announced Dec 16, 2024 · CA · 138 affected
Low
H-1B base pay
Oct 2025 – Jun 2026$146,089
Median base · 212 filings
Middle half of filings
- Medical Scientists, Except Epidemiologists26$146,876
- Software Developers18$155,000
- Statisticians17$146,069
- Chemists14$134,500
North Chicago, IL (84) · Mettawa, IL (25) · South San Francisco, CA (15)
Base wage on public H-1B filings, filed as AbbVie Inc.. Stock and bonus are not included. U.S. Department of Labor, LCA disclosure
AI Layoff Impact Summary
AI-poweredAbbVie announced layoffs on Oct 23, 2024, affecting 138 employees (0.3% of workforce). WARN filings indicate 11 active notices. Low risk — company appears stable.
All Posts
Everything in one feed
Severance packages and next steps for the affected
Just checking in to see if any of the folks impacted by the mid-December layoffs have received their official separation packets yet. I know a few colleagues who got the news this week, and the communication has been pretty sparse regarding what the support actually looks like. Is anyone looking at the WARN notice details and trying to figure out if there’s any potential for redeployment, or are they just slamming the door on everyone? I’ve been through a re-org before, but the timeline here feels really aggressive. If you are one of the 138, have they offered any actual outplacement services, or is it just the standard severance pay and a 'good luck' email? I’m worried that the internal job board is going to be a ghost town while they push all these headcount reductions through. Trying to decide if I should start burning my vacation time and focusing entirely on interviewing elsewhere. Stay strong everyone, this company doesn't care about your tenure when the stock price needs a boost.
Is the culture shifting after the latest round?
I’ve been at AbbVie for a few years now, and honestly, the mood in my department is completely shot. Ever since the news broke about the 138 cuts in California, nobody is talking about project goals or long-term strategy anymore. It’s just constant whispers in the hallway and people checking their calendars for '1-on-1s with HR' with pure dread. I’ve noticed a lot of leadership talk about 'synergy' and 'efficiency' lately, but we all know that’s code for trimming the headcount. Does anyone know if this is going to bleed into the Midwest hubs or the commercial teams in the coming months? It feels like we are constantly looking over our shoulders, and it’s making it impossible to actually focus on our deliverables. I’m starting to wonder if the people who survived this round are actually the lucky ones, or if we’re just waiting for the next tranche of 'efficiency' measures to hit. Curious if anyone in R&D or Sales has heard anything concrete, or if we’re all just guessing at this point.
Is the pipeline being prioritized over people again?
I’m honestly exhausted by the constant pivot in strategy. It feels like every six months we hear about 'refocusing the portfolio,' which is just code for cutting staff to make the margin look better for shareholders. I understand we have to remain competitive, but how much more can they strip from the core teams before we stop being able to deliver on the current assets? The level of anxiety in my team is at an all-time high. Everyone is looking over their shoulders, and productivity has tanked because nobody knows if their project is getting shelved by Q1. Leadership keeps pushing the 'innovation' narrative, but it’s hard to innovate when you’re worried about whether you’ll have a job in 60 days. Has anyone else felt like the mission is being buried under the sheer weight of these constant restructures? It used to feel like a place where you could build a career, now it just feels like a gig economy job with better benefits.
Another round of WARN notices just hit California
Just saw the filing for the 138 cuts in CA effective mid-December. It’s always the same story—leadership talks about 'streamlining' and 'operational efficiency' while the rest of us are left checking our emails every five minutes waiting for that invite from HR. The timing right before the holidays is particularly brutal. Is anyone else seeing shifts in their specific therapeutic areas, or is this still localized to the CA site? I’m starting to get the feeling that no department is truly safe, regardless of what they said during the last all-hands. I’ve been here for years, but the culture has shifted so much since the integration. It feels like we’re just numbers on a spreadsheet now rather than people working on actual medicine. If you’re in one of the impacted groups, hang in there—the market is tough right now, but start updating those resumes immediately if you haven't already.
Middle management burnout is real right now
I’m honestly at my breaking point. I’m a mid-level lead and I feel like I’m constantly stuck in the middle of a squeeze. Corporate keeps pushing down these aggressive KPIs, but then they turn around and freeze our travel budgets and contractor spend. I’m expected to deliver the same output as last year with 30% fewer resources. Every day feels like a masterclass in gaslighting. We get emails about 'innovation' and 'patient centricity,' while at the same time we’re being told to cut corners in ways that feel risky from a compliance standpoint. It’s draining. I’m seeing some of our best talent jumping ship to smaller biotech firms that aren't dealing with this level of bureaucratic paralysis. I love the mission, but I can't keep justifying the stress to my family when the internal culture feels like it’s cannibalizing itself. If you're a high performer, you're basically being punished for it by having to pick up the slack for everyone who left and wasn't replaced. Is anyone actually enjoying their role anymore, or is everyone just coasting and looking for an exit?
Any rumblings about Q3 restructuring?
Is anyone else feeling the shift in tone lately? Ever since the last earnings call, leadership has been hyper-focused on 'operational efficiency' and 'realigning resources.' Every single meeting I'm in lately includes some vague comment about 'staying lean' and 'focusing on high-growth assets.' I’ve been here for over five years and this feels different than the usual end-of-quarter push. We’ve seen several projects get paused indefinitely, and the hiring freeze in my department is still very much in effect. My manager keeps dodging questions about headcount projections for next year, which honestly just makes me more nervous. Are we just waiting for the other shoe to drop before the fiscal year ends? I’m checking my resume and LinkedIn status daily now because I’d rather be prepared than blindsided. Anyone hearing anything specific, or is this just the new normal of industry-wide anxiety?
Feeling the pressure to do more with less
It’s getting exhausting. We had two people resign in my group last month and HR hasn't even posted the roles. Management is telling us to 'prioritize effectively' while the list of deliverables keeps expanding. We’re being pushed to hit aggressive targets with half the support we had this time last year. Honestly, it feels like they’re intentionally running us into the ground to see how much we can handle before we quit, or they’re just trying to keep the metrics high for a potential restructuring announcement. It’s hard to focus on the pipeline when I’m spending half my day doing admin work for a role that shouldn't even be mine. Is anyone else actually seeing meaningful support, or is everyone just burning out in silence?
Is the Humira cliff finally hitting us internally?
Anyone else noticing the shift in tone during the recent town halls? It feels like we’re pivoting hard to cover the revenue gaps, but the communication is becoming increasingly vague. I’ve been hearing whispers about 'operational efficiencies' starting in Q3. Usually, when leadership stops talking about growth and starts emphasizing 'streamlining,' the axe isn't far behind. My director is suddenly unreachable and the budget for our department was cut mid-cycle without a clear explanation. Is this just standard fiscal conservatism, or are they prepping the books for a headcount reduction before the end of the year? Would love to know if other divisions are seeing similar budget freezes or if it’s just my silo getting gutted.
AbbVie - My team's workload has doubled, yet no new hires?
Seriously, what's going on? My team has lost two people in the last quarter due to 'voluntary separation' (you know what that means). We were already stretched thin, and now we're drowning. My manager keeps saying 'we're looking into headcount,' but it's been weeks. The projects aren't getting pushed back, deadlines are still firm, and the expectation is that we just 'do more with less.' It's exhausting and frankly, feels unsustainable. It's not like we're in a dying department; we're critical to several key product lines. I'm starting to wonder if this is a deliberate strategy to see how much people can take before they break, or if they're just hoping we'll all quit so they don't have to pay severance. The pressure is immense, and morale is tanking faster than our stock price (kidding... mostly). Anyone else's team in a similar boat?
AbbVie - Anyone else seeing a hiring freeze? Feels quiet...
Hey everyone, been at AbbVie for a few years now, primarily in R&D. Lately, it feels like the brakes have been put on a lot of things. Internal job postings seem to be disappearing or staying up for ages with no movement. I've heard whispers, but nothing concrete. Some teams are definitely leaner than they were even 6 months ago, but no official word on layoffs. Just this general 'quiet' that's making me a bit uneasy. Performance reviews are coming up, and the usual 'grow your career here' rhetoric feels a little hollow right now. Anyone else in different departments picking up on the same vibes? Is it just my perception, or is there a broader slowdown happening across the company that management isn't talking about?
AbbVie - Internal transfers drying up?
Hi all, I'm currently exploring internal opportunities at AbbVie to move into a different department. I've been keeping an eye on the internal job board for a while, and it seems like the number of posted openings has significantly decreased over the past couple of months. Usually, there's a decent flow, but now it's pretty sparse. On top of that, I reached out to a hiring manager in a department I'm interested in, and they mentioned that while they like my profile, they're currently on a "hiring pause" for most roles, and they don't have a clear timeline for when that might lift. This is happening across a few different teams I've spoken to informally. This is coupled with the general feeling of project delays and general slowdowns that some others have mentioned. It's making it tough to plan career moves within the company. Is anyone else seeing this same trend with internal mobility or experiencing hiring freezes in their departments? Just trying to understand the broader picture here.
AbbVie - Uncertainty creeping in, anyone else feeling it?
Hey everyone, Been at AbbVie for a few years now, and lately, there's been a strange vibe in the air. It's not anything concrete, no official announcements or anything, but you can feel it. Project timelines seem to be stretching, some internal discussions are getting a bit vague about future headcount, and there's definitely a cautiousness that wasn't there before. I know it's a big company and things fluctuate, but this feels different. Performance reviews just wrapped up, and while mine was okay, I've heard rumblings about some teams not hitting targets and less-than-stellar feedback overall. Makes you wonder if this is just normal business cycle stuff or if something bigger is brewing behind the scenes. Just trying to gauge if others are picking up on this too, or if I'm just overthinking it. Curious to hear if anyone has insights or has experienced similar quiet periods that eventually led to changes. Trying to stay positive but also want to be realistic about the situation.
AbbVie - Questions about performance reviews and impact on future roles
So, performance review season is coming up, and honestly, I'm feeling a bit uneasy. There's been a lot of talk about 'strategic realignments' and 'efficiency improvements' lately, which sounds like corporate speak for 'we might be looking at headcount.' I've been doing my best, hitting my goals, but the pressure feels higher than ever. I'm wondering how these reviews are being weighted this year, especially if there's any kind of potential reduction in force down the line. Are managers being given specific targets for ratings? Is it more about overall contribution or hitting very specific, potentially shifting, metrics? Trying to prepare myself and understand what might be coming. Any advice on how to navigate this, or has anyone heard anything specific about how performance is being evaluated in the current climate at AbbVie? Feeling a bit anxious about how my contributions are being perceived.
AbbVie - Anyone else noticing hiring freezes and project delays?
Hey everyone, Been at AbbVie for a few years now, and lately, things feel… weird. We've had a few roles go quiet after posting, and some projects I was expecting to kick off are suddenly on indefinite hold. There's no official word, but the vibe in my department is definitely cautious. Feels like the purse strings are being tightened. Anyone else in other areas of the company seeing similar things? Is it a company-wide thing, or just my division? Trying to get a sense of the overall climate without resorting to rumor mills, but it's hard not to notice the shift. Just wondering if anyone has any insights or is experiencing the same thing. Curious about what's actually going on behind the scenes.
Feeling undervalued and overworked at AbbVie lately. Anyone else?
Just venting here, but has anyone else at AbbVie felt like the workload has ramped up significantly without any corresponding increase in recognition or resources? I'm in a mid-level role and it feels like we're being asked to do more with less, and the pressure is constantly on. Performance reviews have been okay, but the general feeling is that 'good enough' is the new 'great'. I'm seeing colleagues looking stressed, and there's a definite sense of 'hustle harder' without much clarity on the 'why'. It makes you wonder what the long-term plan is for us. Are they trying to push people out, or is this just a temporary squeeze? Not looking for layoff news specifically, but more about the general morale and workload distribution across the company. Anyone else feeling this burn and want to commiserate or share strategies for coping?
AbbVie - Rumblings of a restructure? Seeing some odd project prioritization
Hey everyone, Been at AbbVie for a few years now, mostly in R&D. Lately, things have felt... different. Budgets are definitely tighter, that's for sure. But it's not just the money. It's the way projects are being prioritized. Some things that seemed like slam dunks a year ago are now getting put on the back burner, while others that were lower on the totem pole are suddenly getting all the resources. It's causing a lot of confusion and frankly, some anxiety among my team. We're not hearing official word about layoffs, but this feels like the kind of precursor you hear about in other companies when they're getting ready for a shake-up. Anyone else in different departments seeing similar shifts in focus or hearing whispers about organizational changes? Curious if this is an AbbVie-wide thing or if it's specific to certain areas. Just trying to get a read on the general vibe.
AbbVie: Budgets tight, projects scrutinized. What gives?
Been noticing some serious budget tightening across my team at AbbVie. Seems like every expense, big or small, is getting an extra layer of review. Also, some projects that were previously greenlit are now under intense scrutiny, with questions about ROI and immediate impact. It's creating a bit of uncertainty and making it hard to plan long-term. It's not outright layoffs, but it feels like the precursor to some belt-tightening. Anyone else experiencing this? What's the word on the street from other parts of the company? Wondering if this is a strategic pivot or just a general economic downturn response.
Anyone else feeling the chill at AbbVie?
Hey all, been with AbbVie for a few years now in [department, e.g., R&D/Commercial]. Lately, the atmosphere feels... off. Not hearing direct layoff talk, but there's a definite shift. Hiring freezes in some areas, project scopes being re-evaluated more aggressively, and just a general sense of caution. My manager is being cagey about future headcount. Is anyone else in different departments seeing similar trends? Just trying to gauge if this is a company-wide thing or if I'm just in a bubble. Trying not to spiral, but the whispers are getting louder.
Is AbbVie quietly making changes? Concerned.
Curious if anyone else is feeling a shift at AbbVie. We haven't had any major announcements or town halls discussing significant workforce changes, but there's a distinct undercurrent of uncertainty. My manager has been really cagey about Q4 planning, and there's talk about certain initiatives being put on indefinite hold. I've also observed a noticeable increase in people polishing their LinkedIn profiles and having hushed conversations in the breakroom. It feels like more than just typical end-of-year jitters. Has anyone experienced a sudden freeze on travel or external training requests? Or maybe changes to performance review criteria that seem a bit harsher than usual? Trying to gauge if this is a company-wide sentiment or if I'm just picking up on noise within my specific group. Any insights would be appreciated.
AbbVie: What's the vibe? Seeing weird signs.
Hey everyone, throwing this out there anonymously because I'm genuinely trying to get a pulse on things at AbbVie. No official word on layoffs, but the atmosphere feels... off. Been noticing some odd signals lately. My team's project scope got significantly narrowed last week with a vague explanation about "strategic realignment." Also heard through the grapevine that some external contractors were let go without much fanfare. Hiring on my end has definitely stalled; jobs that were open for months are now just gone from the internal portal. Is anyone else in different departments seeing similar things? Are budgets really tightening up across the board, or is this just localized weirdness? Trying to figure out if it's worth updating the resume just in case, or if I'm overthinking it. Any intel from R&D, Commercial, or Mfg would be super helpful.
Heard whispers about 'restructuring' - any concrete info?
Been hearing a lot of talk lately about 'strategic realignments' and 'organizational restructuring' within AbbVie. Sounds like corporate speak for something bigger, but nobody seems to have details. Some departments are apparently being consolidated, and there are rumors of roles being 'evaluated'. This isn't coming from official comms, just hallway whispers and LinkedIn rumors. Anyone in R&D, Manufacturing, or Commercial have any more concrete intel on what this 'restructuring' actually entails? Are we talking about significant headcount changes, or just shuffling the deck chairs? Trying to get a sense of the reality on the ground before panic sets in. Any insights would be greatly appreciated.
Anyone else seeing budget cuts or hiring freezes without an official announcement?
Hey all, been at AbbVie for a few years now, and lately things feel… strange. We haven't had any official word about layoffs, but there's a definite chill in the air. My team's travel budget got slashed overnight, and a few open requisitions for critical roles have just gone dark. It feels like a hiring freeze, but no one is saying it out loud. Managers are being super cagey when asked about hiring plans. Is anyone else experiencing this quiet tightening of the purse strings? It's making it hard to plan and, honestly, a bit unsettling. Wondering if this is an ABBV-wide thing or just specific to certain divisions. Let me know if you're seeing similar signals.
Performance review focus shifting dramatically?
My last few performance reviews at AbbVie have been standard fare. This year, though, it feels like the whole conversation has pivoted. Instead of focusing on project successes and skill development, it's all about 'value demonstration' and 'impact metrics.' My manager is talking a lot about how individual contributions need to be more quantifiable and directly tied to the bottom line. It's making me nervous. It feels like they're setting a new bar, and I'm worried about what happens if you don't clear it. It's not just my review; I'm hearing similar themes from colleagues in other teams. Is this a new company-wide performance management push, or is it a precursor to something else? Feels like a lot of pressure to prove your worth in very specific, possibly arbitrary, ways.
Odd reshuffling in my department - anyone else?
Been at AbbVie for a few years now, and lately things feel... different. My department, usually pretty stable, has seen a bunch of people either move around, take on new 'special projects,' or suddenly have their roles redefined. It's not outright layoffs, as far as I can tell, but it's definitely a lot of churn. Management is using terms like 'strategic realignment' and 'optimizing workflows,' but the actual impact feels like everyone's being nudged into new spaces without a clear roadmap. Some folks seem excited about the new opportunities, but I'm seeing more quiet confusion and hushed conversations. Anyone else experiencing this kind of internal shuffle? Trying to figure out if this is a company-wide thing or just my corner of the pharma world.
Anyone else seeing unexpected 'talent acquisition' reviews?
Been hearing whispers through the grapevine about a more rigorous review process for open roles, especially those that aren't in immediate R&D or critical manufacturing. It's not a full stop, but it feels like every single position outside the absolute essentials is getting a really hard look before it gets approved. We've got a couple of roles on my team that have been open for months, and the hiring manager seems to be getting grilled on the necessity every time they check in. This wasn't the case even six months ago. Anyone else experiencing this in their departments? Trying to figure out if it's a company-wide thing or just specific to certain divisions.
Rethinking our core competencies lately?
Lately, I've been feeling a weird vibe in strategy meetings. It feels like we're constantly questioning what we're good at, or what's even important anymore. There's a lot of talk about 'streamlining' and 'focusing on core therapeutic areas,' but it's not translating into clear direction for many of us. More like a vague sense of unease. My projects are still moving, but the 'why' behind them feels less certain. Is anyone else getting this impression? It feels like a lot of re-evaluation is happening, but without a lot of concrete outcomes or communication about what it means for the long term. Just a lot of abstract buzzwords being thrown around.
Sudden push for 'efficiency improvements' in my division
Over the past couple of months, there's been a really aggressive push from senior leadership in my division about 'efficiency improvements' and 'streamlining processes'. It started with a lot of data analysis requests and process mapping exercises. Now, we're seeing these mandatory workshops and training sessions popping up, all focused on how to 'optimize workflows' and 'reduce redundancies'. Honestly, it feels like they're laying the groundwork for something. There haven't been any official announcements about layoffs, but the constant talk about 'right-sizing' and 'resource allocation' is making me nervous. My manager is being cagey when I ask for specifics about what these 'improvements' actually entail or what the end goal is. Just feels like a lot of activity without clear communication on the 'why' behind it all.
Morale seems to be taking a hit. Am I imagining it?
Lately, the general vibe in the office (or on Teams calls, since most of us are hybrid) just feels... off. People seem more withdrawn, less likely to engage in casual chat, and there's this undercurrent of anxiety. I've heard whispers about certain departments being 'streamlined' or projects being put on hold indefinitely, but nothing concrete. It's like everyone's walking on eggshells, afraid to ask too many questions or draw attention. Even team meetings feel more subdued, with less brainstorming and more just 'checking the box'. I'm trying to stay positive and focused on my work, but it's hard when you feel like there's a storm brewing just over the horizon. Anyone else picking up on this, or is it just my team/department?
Is anyone else's team suddenly 'restructuring' without any clear communication?
Been hearing a lot of buzzwords around my department lately – 'synergies,' 'streamlining,' 'realigning.' But nobody can give a straight answer on what it actually means. Roles are being subtly shifted, responsibilities are being redistributed, and there's a general air of uncertainty. It's not like there's an official announcement or anything, just a slow drip of changes. And the usual channels for information are either silent or giving vague, corporate-speak answers. Makes you wonder what the end goal is and if it's more than just a simple reorg. Anyone else experiencing this slow-motion 'restructuring' without clarity?
Project timelines getting aggressively compressed?
Lately, it feels like every project I'm on has had its deadlines slashed. Not just by a few days, but significantly. My manager keeps saying it's about 'driving efficiency' and 'accelerating innovation,' but it's leading to a ton of overtime and frankly, a lot of corners being cut. We're skipping validation steps, reducing scope on non-critical path items, and the quality is starting to suffer. Anyone else seeing this kind of pressure to just get things done *faster* regardless of the impact on long-term maintainability or even current output quality? Feels like a recipe for disaster down the line.